Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.

Scientific reports·2022
Same author

Prospective international validation of the predisposition, infection, response and organ dysfunction (PIRO) clinical staging system among intensive care and general ward patients.

Annals of intensive care·2021
Same author

The effect of agricultural intensification and water-locking on the world's largest coastal lagoonal system.

The Science of the total environment·2021
Same author

Impact of g force and timing on the characteristics of platelet-rich fibrin matrices.

Scientific reports·2021
Same author

Background levels of trace elements in brown and red seaweeds from Trindade, a remote island in South Atlantic Ocean.

Marine pollution bulletin·2018
Same author

Diazoxide enhances excitotoxicity-induced neurogenesis and attenuates neurodegeneration in the rat non-neurogenic hippocampus.

Neuroscience·2016
Same journal

Anemia associated with long-acting injectable aripiprazole in an elderly man.

Indian journal of psychiatry·2026
Same journal

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026
Same journal

Proposal of 'World Psychiatry Day': The aim is to celebrate psychiatry as the third division of medicine alongside internal medicine and general surgery.

Indian journal of psychiatry·2026
Same journal

A bibliometric assessment of the <i>Indian Journal of Psychiatry</i>: Trends, impact, and collaboration (2009-2024).

Indian journal of psychiatry·2026
Same journal

Narcotic bowel syndrome misdiagnosed as somatoform pain disorder and presenting with opioid use disorder - A case report.

Indian journal of psychiatry·2026
Same journal

From tramadol to pregabalin addiction: A case report of unsupervised substance substitution and temporally improved in craving with fluoxetine.

Indian journal of psychiatry·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

Fluoxetine and vascular headaches.

C Andrade1

  • 1Associate Professor, Department of Psychopharmacology, National Institute of Mental Health and Neuro Sciences, Bangalore - 560 029.

Indian Journal of Psychiatry
|July 12, 2011
PubMed
Summary
This summary is machine-generated.

Vascular headaches can be a side effect of fluoxetine, an antidepressant. This report details a case of a patient experiencing these headaches during depression treatment.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Related Experiment Videos

Last Updated: May 31, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Headaches are a frequent adverse effect associated with fluoxetine treatment.
  • Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are commonly prescribed for depression.
  • Understanding drug-induced adverse effects is crucial for patient safety and treatment adherence.

Purpose of the Study:

  • To report a case of a patient who developed vascular headaches during fluoxetine therapy for depression.
  • To discuss the potential mechanisms underlying fluoxetine-induced vascular headaches.

Main Methods:

  • Case report detailing a patient's clinical presentation and treatment course.
  • Literature review on the adverse effects of fluoxetine and vascular headaches.

Main Results:

  • The patient experienced significant vascular headaches attributed to fluoxetine therapy.
  • Analysis suggests potential serotonergic and vascular mechanisms contributing to the headaches.

Conclusions:

  • Fluoxetine can precipitate vascular headaches in susceptible individuals.
  • Further research into the neurobiological mechanisms is warranted to mitigate this adverse effect.